Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A. |
Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A. |
Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A. |
Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. |
Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. |
Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. |
Sci Rep. |
Sci Rep. |
Sci Rep. |
2019/06 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A. |
Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A. |
Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A. |
Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells. |
Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells. |
Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells. |
Sci Rep., doi: 10.1038/s41598-019-43575- |
Sci Rep., doi: 10.1038/s41598-019-43575- |
Sci Rep., doi: 10.1038/s41598-019-43575- |
2019/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T. |
Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T. |
Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T. |
Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association. |
Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association. |
Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association. |
Front Cell Infect Microbiol. |
Front Cell Infect Microbiol. |
Front Cell Infect Microbiol. |
2019/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A. |
Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A. |
Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A. |
A screening for DNA damage response molecules that affect HIV-1 infection.  |
A screening for DNA damage response molecules that affect HIV-1 infection.  |
A screening for DNA damage response molecules that affect HIV-1 infection.  |
Biochem Biophys Res Commun., 21, 513, 93-98 |
Biochem Biophys Res Commun., 21, 513, 93-98 |
Biochem Biophys Res Commun., 21, 513, 93-98 |
2019/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H. |
Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H. |
Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H. |
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder. |
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder. |
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder. |
Intern Med. |
Intern Med. |
Intern Med. |
2018/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A. |
Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A. |
Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A. |
Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.  |
Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.  |
Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.  |
Cancer Sci., 109, 1, 103-111 |
Cancer Sci., 109, 1, 103-111 |
Cancer Sci., 109, 1, 103-111 |
2018/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A. |
Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A. |
Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A. |
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia. |
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia. |
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia. |
Sci Rep., 7, 1, 12849 |
Sci Rep., 7, 1, 12849 |
Sci Rep., 7, 1, 12849 |
2017/10 |
Refereed |
English |
|
Disclose to all |
Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A |
Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A |
Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A |
Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation. |
Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation. |
Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation. |
The Journal of biological chemistry, 291, 48, 24892-24899 |
The Journal of biological chemistry, 291, 48, 24892-24899 |
The Journal of biological chemistry, 291, 48, 24892-24899 |
2016/11 |
Refereed |
|
|
Disclose to all |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Expression of Tim-1 in primary CNS lymphoma.  |
Expression of Tim-1 in primary CNS lymphoma.  |
Expression of Tim-1 in primary CNS lymphoma.  |
Cancer medicine, 5, 11, 3235-3245 |
Cancer medicine, 5, 11, 3235-3245 |
Cancer medicine, 5, 11, 3235-3245 |
2016/11 |
Refereed |
|
|
Disclose to all |
Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A |
Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A |
Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A |
Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. |
Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. |
Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. |
Biochemical and biophysical research communications, 478, 3, 1466-1471 |
Biochemical and biophysical research communications, 478, 3, 1466-1471 |
Biochemical and biophysical research communications, 478, 3, 1466-1471 |
2016/09 |
Refereed |
|
|
Disclose to all |
Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E. |
Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E. |
Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E. |
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.  |
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.  |
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.  |
Elife., 31, 5, e11156 |
Elife., 31, 5, e11156 |
Elife., 31, 5, e11156 |
2016/05 |
Refereed |
English |
|
Disclose to all |
Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J. |
白川 康太郎Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J. |
Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J. |
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype. |
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype. |
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype. |
Cell Metab., 9, 23, 303-314 |
Cell Metab., 9, 23, 303-314 |
Cell Metab., 9, 23, 303-314 |
2016/02 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L. |
Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L. |
Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L. |
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. |
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. |
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. |
Nat Med., 21, 10, 1154-1162 |
Nat Med., 21, 10, 1154-1162 |
Nat Med., 21, 10, 1154-1162 |
2015/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E |
Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E |
Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E |
SIRT1 deacetylates RORγt and enhances Th17 cell generation. |
SIRT1 deacetylates RORγt and enhances Th17 cell generation. |
SIRT1 deacetylates RORγt and enhances Th17 cell generation. |
The Journal of experimental medicine, 212, 5, 607-617 |
The Journal of experimental medicine, 212, 5, 607-617 |
The Journal of experimental medicine, 212, 5, 607-617 |
2015/05 |
Refereed |
|
|
Disclose to all |
Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A. |
Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A. |
Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A. |
Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia. |
Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia. |
Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia. |
Sci Adv., 24, 1, e1400203. |
Sci Adv., 24, 1, e1400203. |
Sci Adv., 24, 1, e1400203. |
2015/04 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A |
Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A |
Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A |
Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome. |
Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome. |
Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome. |
[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316 |
[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316 |
[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316 |
2015 |
Refereed |
|
|
Disclose to all |
Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E |
Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E |
Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E |
Reactivation of latent HIV by histone deacetylase inhibitors. |
Reactivation of latent HIV by histone deacetylase inhibitors. |
Reactivation of latent HIV by histone deacetylase inhibitors. |
Trends in microbiology, 21, 6, 277-285 |
Trends in microbiology, 21, 6, 277-285 |
Trends in microbiology, 21, 6, 277-285 |
2013/06 |
Refereed |
|
|
Disclose to all |
Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E |
Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E |
Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E |
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. |
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. |
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. |
Science (New York, N.Y.), 339, 6116, 211-214 |
Science (New York, N.Y.), 339, 6116, 211-214 |
Science (New York, N.Y.), 339, 6116, 211-214 |
2013/01 |
Refereed |
|
|
Disclose to all |
Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V |
Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V |
Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V |
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. |
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. |
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. |
PLoS pathogens, 9, 12, e1003834 |
PLoS pathogens, 9, 12, e1003834 |
PLoS pathogens, 9, 12, e1003834 |
2013 |
Refereed |
|
|
Disclose to all |
Hakre S, Chavez L, Shirakawa K, Verdin E |
Hakre S, Chavez L, Shirakawa K, Verdin E |
Hakre S, Chavez L, Shirakawa K, Verdin E |
HIV latency: experimental systems and molecular models. |
HIV latency: experimental systems and molecular models. |
HIV latency: experimental systems and molecular models. |
FEMS microbiology reviews, 36, 3, 706-716 |
FEMS microbiology reviews, 36, 3, 706-716 |
FEMS microbiology reviews, 36, 3, 706-716 |
2012/05 |
Refereed |
|
|
Disclose to all |
Hakre S, Chavez L, Shirakawa K, Verdin E |
Hakre S, Chavez L, Shirakawa K, Verdin E |
Hakre S, Chavez L, Shirakawa K, Verdin E |
Epigenetic regulation of HIV latency. |
Epigenetic regulation of HIV latency. |
Epigenetic regulation of HIV latency. |
Current opinion in HIV and AIDS, 6, 1, 19-24 |
Current opinion in HIV and AIDS, 6, 1, 19-24 |
Current opinion in HIV and AIDS, 6, 1, 19-24 |
2011/01 |
Refereed |
|
|
Disclose to all |
Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A |
Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A |
Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A |
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.  |
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.  |
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.  |
Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803 |
Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803 |
Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803 |
2010/11 |
Refereed |
|
|
Disclose to all |
Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T |
Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T |
Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T |
MDM2 is a novel E3 ligase for HIV-1 Vif.  |
MDM2 is a novel E3 ligase for HIV-1 Vif.  |
MDM2 is a novel E3 ligase for HIV-1 Vif.  |
Retrovirology, 6, 1 |
Retrovirology, 6, 1 |
Retrovirology, 6, 1 |
2009/01 |
Refereed |
|
|
Disclose to all |
Kotaro SirakawaShirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T. |
Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T. |
Kotaro SirakawaShirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T. |
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. |
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. |
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. |
Nat Struct Mol Biol., 15, 11, 1184-1191 |
Nat Struct Mol Biol., 15, 11, 1184-1191 |
Nat Struct Mol Biol., 15, 11, 1184-1191 |
2008/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Izumi T, Shirakawa K, Takaori-Kondo A. |
Izumi T, Shirakawa K, Takaori-Kondo A. |
Izumi T, Shirakawa K, Takaori-Kondo A. |
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. |
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. |
Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. |
Mini Rev Med Chem., 8, 3, 231-238 |
Mini Rev Med Chem., 8, 3, 231-238 |
Mini Rev Med Chem., 8, 3, 231-238 |
2008/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K. |
Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K. |
Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K. |
Dual effect of APOBEC3G on Hepatitis B virus. |
Dual effect of APOBEC3G on Hepatitis B virus. |
Dual effect of APOBEC3G on Hepatitis B virus. |
J Gen Virol., 88, 2, 432-440 |
J Gen Virol., 88, 2, 432-440 |
J Gen Virol., 88, 2, 432-440 |
2007/02 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T. |
Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T. |
Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T. |
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. |
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. |
Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. |
Curr Biol., 16, 15, 1565-1570 |
Curr Biol., 16, 15, 1565-1570 |
Curr Biol., 16, 15, 1565-1570 |
2006/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T. |
Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T. |
Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T. |
Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. |
Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. |
Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. |
Virology., 344, 2, 263-266 |
Virology., 344, 2, 263-266 |
Virology., 344, 2, 263-266 |
2006/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T. |
Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T. |
Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T. |
APOBEC3G targets human T-cell leukemia virus type 1. |
APOBEC3G targets human T-cell leukemia virus type 1. |
APOBEC3G targets human T-cell leukemia virus type 1. |
Retrovirology., 19, 2, 32 |
Retrovirology., 19, 2, 32 |
Retrovirology., 19, 2, 32 |
2005/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y. |
Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y. |
Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y. |
[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification]. |
[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification]. |
[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification]. |
Rinsho Ketsueki., 45, 1, 48-56 |
Rinsho Ketsueki., 45, 1, 48-56 |
Rinsho Ketsueki., 45, 1, 48-56 |
2004/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |